3/30/2024 | 30042039 | NORKIN PLUS SUSPENSION (NORFLOXACIN I.P100MG+METRONIDAZOLE 100MG./5ML SUSPENSION) B/N. AU23092 M/D. 02/2024 E/D 01/2027 | XXXXXXXXXX | 52500 | NOS | 7024.35 | AFGHANISTAN | PATLI ICD |
3/23/2024 | 30042039 | NORKIN PLUS SUSPENSION(NORFLOXACIN I.P 100MG+METRONIDAZOLE 100MG./5ML SUSPENSION) B/N AU23091,92 M/D 02/2024 E/D 01/2027 | XXXXXXXXXX | 31500 | NOS | 4198.69 | AFGHANISTAN | PATLI ICD |
3/23/2024 | 30042039 | NORKIN PLUS SUSPENSION(NORFLOXACIN I.P100MG+METRONIDAZOLE 100MG.5ML SUSPENSION B/N.AU23089,90,91 M/D 02/2024 E/D 01/2027 | XXXXXXXXXX | 123900 | NOS | 12859.8 | AFGHANISTAN | PATLI ICD |
3/16/2024 | 30042039 | NORKIN PLUS SUSPENSION (NORFLOXACIN I.P100 MG + METRONIDAZOLE 100MG./5ML SUSPENSION) BATCH NO.: AU23089 | XXXXXXXXXX | 43400 | NOS | 5839.34 | PAKISTAN | PATLI ICD |
3/6/2024 | 30042039 | NORKIN PLUS SUSPENSION(NORFLOXACIN I.P100MG+METRONIDAZOLE 100MG./5ML SUSPENSIO B/N: AU23087,88,89 M/D 02/2024 | XXXXXXXXXX | 152600 | NOS | 20374.85 | AFGHANISTAN | PATLI ICD |
3/5/2024 | 30042039 | NORKIN PLUS SUSPENSION(NORFLOXACIN I.P100MG+METRONIDAZOLE 100MG./5ML SUSPENSIONB/N AU23086 M/D 02/2024 E/D 01/2027 | XXXXXXXXXX | 65800 | NOS | 8785.45 | AFGHANISTAN | PATLI ICD |
2/9/2024 | 30042039 | NORKIN PLUS SUSPENSION (NORFLOXACIN I.P100 MG + METRONIDAZOLE 100MG./5ML SUSPENSION) BATCH NO.: AU23082NOS | XXXXXXXXXX | 8036 | NOS | 932.14 | AFGHANISTAN | PATLI ICD |
2/9/2024 | 30042039 | NORKIN PLUS SUSPENSION (NORFLOXACIN I.P100 MG + METRONIDAZOLE 100MG./5ML SUSPENSION) BATCH NO.: AU23082NOS | XXXXXXXXXX | 10906 | NOS | 1265.05 | AFGHANISTAN | PATLI ICD |
2/9/2024 | 30042039 | NORKIN PLUS SUSPENSION (NORFLOXACIN I.P100 MG + METRONIDAZOLE 100MG./5ML SUSPENSION) BATCH NO.: AU23082NOS | XXXXXXXXXX | 9758 | NOS | 1131.89 | AFGHANISTAN | PATLI ICD |
2/6/2024 | 30042039 | PHARMACEUTICALS PRODUCTS - ( FINISHED PRODUCT) NORMET 200/200 MG TABLET 10X1X10( METRONIDAZOLE & NORFLOXACIN TABLETS 2NOS | XXXXXXXXXX | 1980 | NOS | 7425.2 | FRANCE | JNPT |